Model for aging in the basal forebrain cholinergic system

Antioxidants and Redox Signaling

Volumn 2, Issue 3, 2000, Pages 437-447

  Gu, Zezong ^a   Wortwein, Gitta ^a   Yu, Juan ^a   Perez Polo, J Regino ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOTOXIN; NERVE GROWTH FACTOR; SAPORIN;

AGING; APOPTOSIS; BRAIN INJURY; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; FOREBRAIN; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SIGNAL TRANSDUCTION;

AGING; ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN; CENTRAL NERVOUS SYSTEM; CHOLINERGIC AGENTS; HIPPOCAMPUS; HUMANS; IMMUNOTOXINS; N-GLYCOSYL HYDROLASES; NEURONS; NF-KAPPA B; PROSENCEPHALON; RATS; RECEPTORS, CHOLINERGIC;

EID: 0033752814     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/15230860050192215     Document Type: Review

References (121)

1. The inducible transcription activator NF-kappa B: Regulation by distinct protein subunits
2. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor
3. NF-kappa B: Ten years after
4. Function and activation of NF-kappa B in the immune system
5. The cholinergic hypothesis of geriatric memory dysfunction
6. Selective immunotoxic lesions of basal forebrain cholinergic cells: Effects on learning and memory in rats
7. Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis
8. Traumatic spinal cord injury induces nuclear factor-kappaB activation
9. Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer’s disease
10. Specificity of 192 IgG-saporin for NGF receptor-positive cholinergic basal forebrain neurons in the rat
11. 192 IgG-saporin: I. Specific lethality for cholinergic neurons in the basal forebrain of the rat
12. Functional interactions of neurotrophins and neurotrophin receptors
13. Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75
14. Death of oligo-dendrocytes mediated by the interaction of nerve growth factor with its receptor p75
15. Neurotrophin receptors: Mediators of life and death
16. p75 and Trk: A two-receptor system
17. Somatic gene transfer of NGF to the aged brain: Behavioral and morphological amelioration
18. Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-kappaB in rats
19. Alzheimer’s disease: A disorder of cortical cholinergic innervation
20. Oxidative stress, glutamate, and neurodegenerative disorders
21. Suppression of postischemic hippocampal nerve growth factor expression by a co-fos antisense oligodeoxynucleotide
22. The neurotrophic hypothesis: Where does it stand?
23. Selective loss of central cholinergic neurons in Alzheimer’s disease
24. Reduced retrograde labelling with fluorescent tracer accompanies neuronal atrophy of basal forebrain cholinergic neurons in aged rats
25. Memory and cognitive function in man: Does the cholinergic system have a specific role?
26. Choline levels are increased in cerebrospinal fluid of Alzheimer patients
27. NGF improves spatial memory in aged rodents as a function of age
28. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor
29. Nerve growth factor: Two receptors, multiple functions
30. The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons
31. Morphological response of axotomized septal neurons to nerve growth factor
32. NGF receptor reexpression and NGF-mediated cholinergic neuronal hypertrophy in the damaged adult neostriatum
33. Nerve growth factor-induced synaptogenesis and hypertrophy of cortical cholinergic terminals
34. Activation in vitro of NF-kappa B by phosphorylation of its inhibition I kappa B
35. Responses in the aged rat brain after total immunolesion
36. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin
37. Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor
38. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections
39. Pharmacology of neurotrophic factors
40. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions
41. Changes associated with aging and replicative senescence the regulation of transcription factor nuclear factor-kappa B
42. Emerging themes in structural biology of neurotrophic factors
43. Neurotrophin regulation of energy homeostasis in the central nervous system
44. Demonstration of the retrograde transport of nerve growth factor receptor in the peripheral and central nervous system
45. Potential involvement of the transcription factor NF-kappa B in neurological disorders
46. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease
47. Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons
48. Constitutive NF-kappa B activity in neurons
49. Biologic effects of nerve growth factor on lesioned basal forebrain neurons
50. Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues
51. Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis (Ch4) of Alzheimer’s patients
52. The aged monkey basal forebrain: Rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor
53. Selective immunolesioning of the basal forebrain cholinergic system disrupts short-term memory in rats
54. Extensive reinnervation of the hippocampus by embryonic basal forebrain cholinergic neurons grafted into the septum of neonatal rats with selective cholinergic lesions
55. Selective lesioning of the basal forebrain cholinergic system by intraventricular 192 IgG-saporin: Behavioural, biochemical and stereological studies in the rat
56. High constitutive NF-kappaB activity mediates resistance to oxidative stress in neuronal cells
57. Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: Signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B
58. Neurotrophins and receptors
59. Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging
60. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bone involving cysteine 62
61. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration
62. Regulation of the transcription factors NK-kappa B and AP-1 by redox changes
63. H202 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor
64. A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel
65. Spatial learning impairments in rats with selective immunolesion of the forebrain cholinergic system
66. Reduced choline acetyltransferase activity and muscarinic M1 receptor levels in aged Fisher 344 rat brains did not parallel their respective mRNA levels
67. A radical hypothesis for neurodegeneration
68. NF-kappa B: A crucial transcription factor for glial and neuronal cell function
69. Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes
70. Nerve growth factor and oxidative stress in the nervous system
71. Induction of NF-kB-like transcription factors in brain areas susceptible to kainate toxicity
72. Mechanisms of cell death
73. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyl-transferase and glutamic acid decarboxylase activities in necropsy brain tissue
74. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
75. Induction of apoptosis by the low-affinity NGF receptor
76. Acetylcholine and choline levels in post-mortem human brain tissue: Preliminary observations in Alzheimer’s disease
77. 192IgG-saporin immunotoxin-induced loss of cholinergic cells differentially activates microglia in rat basal forebrain nuclei
78. 192IGG-saporin-induced selective lesion of cholinergic basal forebrain system: Neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus
79. Effects of intraventricular transplantation of NGF-secreting cells on cholinergic basal forebrain neurons after partial immunolesion
80. Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer’s disease
81. Alteration of transcription factor binding activities in the ischemic rat brain
82. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1
83. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B
84. Increased NGF-like activity in young but not aged rat hippocampus after septal lesions
85. Nerve growth factor in Alzheimer’s disease: Increased levels throughout the brain coupled with declines in nucleus basalis
86. Structure, regulation and function of NF-kappa B
87. Free radicals and brain damage
88. High-affinity nerve growth factor receptor (Trk) immunoreactivity is localized in cholinergic neurons of the basal forebrain and striatum in the adult rat brain
89. Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: An in situ hybridization study
90. Presence of NF-kappaB-like and IkappaB-like immunoreactivities in postsynaptic densities
91. Suppression of p140trkA does not abolish nerve growth factor-mediated rescue of serum-free PC12 cells
92. Inhibition of nuclear factor kappa B (NFkappaB) activity induces nerve growth factor-resistant apoptosis in PC12 cells
93. Neurotrophic factors
94. The changing scene of neurotrophic factors
95. Neurotrophins and neuronal plasticity
96. The physiological function of nerve growth factor in the central nervous system: Comparison with the periphery
97. Age-associated alterations in hippocampal and basal forebrain nuclear factor kappa B activity
98. Transcription factor DNA binding activity in PC12 cells undergoing apoptosis after glucose deprivation
99. Effect of nerve growth factor on AP-1, NF-kappa B, and Oct DNA binding activity in apoptotic PC12 cells: Extrinsic and intrinsic elements
100. Signal transduction in neuronal death
101. Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system
102. Nerve growth factor infusions combined with fetal hippocampal grafts enhance reconstruction of the lesioned septohippocampal projection
103. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain
104. Activation of NF-kappa B in human skin fibroblasts by the oxidative stress generated by UVA radiation
105. 192 Immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells
106. Alzheimer’s disease and senile dementia: Loss of neurons in the basal forebrain
107. Alzheimer’s disease and related dementias: Selective involvement of specific neuronal systems
108. The expression, localization and functional significance of beta-nerve growth factor in the central nervous system
109. Findings about the cholinergic basal forebrain using immunotoxin to the nerve growth factor receptor
110. Immunolesioning: Selective destruction of neurons using immunotoxin to rat NGF receptor
111. Exogenous nerve growth factor increases the activity of high-affinity choline uptake and choline acetyltransferase in brain of Fisher 344 male rats
112. Nerve growth factor affects the cholinergic neurochemistry and behavior of aged rats
113. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection
114. Responses of young and aged rat CNS to partial cholinergic immunolesions and NGF treatment
115. IkappaB kinase-beta:NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK
116. Immunohistochemical localization and biochemical characterization of nerve growth factor receptor in adult rat brain
117. Increased cortical nuclear factor-kappa B (NF-kappa B) DNA binding activity after traumatic brain injury in rats
118. Mechanisms of neuronal degeneration in Alzheimer’s disease
119. Role of the cholinergic system in the regulation of neurotrophin synthesis
120. Altered NGF protein levels in different brain areas after immunolesion
121. The IkappaB kinase complex (IKK) contains two kinase subunits. IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation